Annual EBIT
-$4.84 M
+$3.75 M+43.67%
October 31, 2024
Summary
- As of February 8, 2025, CMND annual earnings before interest & taxes is -$4.84 million, with the most recent change of +$3.75 million (+43.67%) on October 31, 2024.
- During the last 3 years, CMND annual EBIT has fallen by -$2.15 million (-79.72%).
- CMND annual EBIT is now -5950.75% below its all-time high of -$80.00 thousand, reached on October 1, 2019.
Performance
CMND EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$681.80 K
+$789.40 K+53.66%
October 31, 2024
Summary
- As of February 8, 2025, CMND quarterly earnings before interest & taxes is -$681.80 thousand, with the most recent change of +$789.40 thousand (+53.66%) on October 31, 2024.
- Over the past year, CMND quarterly EBIT has increased by +$3.32 million (+82.96%).
- CMND quarterly EBIT is now -17382.05% below its all-time high of -$3900.00, reached on April 1, 2018.
Performance
CMND Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$4.84 M
+$3.32 M+40.68%
October 31, 2024
Summary
- As of February 8, 2025, CMND TTM earnings before interest & taxes is -$4.84 million, with the most recent change of +$3.32 million (+40.68%) on October 31, 2024.
- Over the past year, CMND TTM EBIT has increased by +$3.75 million (+43.67%).
- CMND TTM EBIT is now -92986.54% below its all-time high of -$5200.00, reached on October 1, 2017.
Performance
CMND TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CMND EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.7% | +83.0% | +43.7% |
| 3 y3 years | -79.7% | +57.3% | -79.7% |
| 5 y5 years | -5950.8% | -3526.6% | -5853.9% |
CMND EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -79.7% | +43.7% | at high | +83.0% | -13.9% | +43.7% |
| 5 y | 5-year | -5950.8% | +43.7% | -3526.6% | +83.0% | -5853.9% | +43.7% |
| alltime | all time | -5950.8% | +43.7% | <-9999.0% | +83.0% | <-9999.0% | +43.7% |
Clearmind Medicine EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | -$4.84 M(-43.7%) | -$681.80 K(-53.7%) | -$4.84 M(-40.7%) |
| Jul 2024 | - | -$1.47 M(+12.9%) | -$8.16 M(+4.7%) |
| Apr 2024 | - | -$1.30 M(-5.8%) | -$7.79 M(-4.3%) |
| Jan 2024 | - | -$1.38 M(-65.4%) | -$8.14 M(-5.2%) |
| Oct 2023 | -$8.59 M(+25.4%) | -$4.00 M(+262.7%) | -$8.59 M(+35.4%) |
| Jul 2023 | - | -$1.10 M(-33.4%) | -$6.34 M(-3.8%) |
| Apr 2023 | - | -$1.66 M(-9.7%) | -$6.59 M(-7.9%) |
| Jan 2023 | - | -$1.83 M(+4.6%) | -$7.16 M(+2.9%) |
| Oct 2022 | -$6.85 M(+154.3%) | -$1.75 M(+29.7%) | -$6.96 M(+2.3%) |
| Jul 2022 | - | -$1.35 M(-39.2%) | -$6.80 M(+7.6%) |
| Apr 2022 | - | -$2.22 M(+35.9%) | -$6.32 M(+48.6%) |
| Jan 2022 | - | -$1.63 M(+2.4%) | -$4.25 M(+57.8%) |
| Oct 2021 | -$2.69 M | - | - |
| Oct 2021 | - | -$1.60 M(+83.9%) | -$2.69 M(+108.7%) |
| Jul 2021 | - | -$867.70 K(+464.2%) | -$1.29 M(+171.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2021 | - | -$153.80 K(+99.5%) | -$476.30 K(+29.8%) |
| Jan 2021 | - | -$77.10 K(-59.9%) | -$367.00 K(+18.9%) |
| Oct 2020 | -$309.90 K(+287.4%) | -$192.10 K(+260.4%) | -$308.70 K(+127.8%) |
| Jul 2020 | - | -$53.30 K(+19.8%) | -$135.50 K(+37.3%) |
| Apr 2020 | - | -$44.50 K(+136.7%) | -$98.70 K(+21.4%) |
| Jan 2020 | - | -$18.80 K(-0.5%) | -$81.30 K(+2.4%) |
| Oct 2019 | -$80.00 K(-58.8%) | -$18.90 K(+14.5%) | -$79.40 K(-62.8%) |
| Jul 2019 | - | -$16.50 K(-39.1%) | -$213.30 K(+0.8%) |
| Apr 2019 | - | -$27.10 K(+60.4%) | -$211.60 K(+12.3%) |
| Jan 2019 | - | -$16.90 K(-88.9%) | -$188.40 K(-3.6%) |
| Oct 2018 | -$194.00 K | -$152.80 K(+932.4%) | -$195.40 K(+308.8%) |
| Jul 2018 | - | -$14.80 K(+279.5%) | -$47.80 K(+44.8%) |
| Apr 2018 | - | -$3900.00(-83.7%) | -$33.00 K(+13.4%) |
| Jan 2018 | - | -$23.90 K(+359.6%) | -$29.10 K(+459.6%) |
| Oct 2017 | - | -$5200.00 | -$5200.00 |
FAQ
- What is Clearmind Medicine annual earnings before interest & taxes?
- What is the all time high annual EBIT for Clearmind Medicine?
- What is Clearmind Medicine annual EBIT year-on-year change?
- What is Clearmind Medicine quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Clearmind Medicine?
- What is Clearmind Medicine quarterly EBIT year-on-year change?
- What is Clearmind Medicine TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Clearmind Medicine?
- What is Clearmind Medicine TTM EBIT year-on-year change?
What is Clearmind Medicine annual earnings before interest & taxes?
The current annual EBIT of CMND is -$4.84 M
What is the all time high annual EBIT for Clearmind Medicine?
Clearmind Medicine all-time high annual earnings before interest & taxes is -$80.00 K
What is Clearmind Medicine annual EBIT year-on-year change?
Over the past year, CMND annual earnings before interest & taxes has changed by +$3.75 M (+43.67%)
What is Clearmind Medicine quarterly earnings before interest & taxes?
The current quarterly EBIT of CMND is -$681.80 K
What is the all time high quarterly EBIT for Clearmind Medicine?
Clearmind Medicine all-time high quarterly earnings before interest & taxes is -$3900.00
What is Clearmind Medicine quarterly EBIT year-on-year change?
Over the past year, CMND quarterly earnings before interest & taxes has changed by +$3.32 M (+82.96%)
What is Clearmind Medicine TTM earnings before interest & taxes?
The current TTM EBIT of CMND is -$4.84 M
What is the all time high TTM EBIT for Clearmind Medicine?
Clearmind Medicine all-time high TTM earnings before interest & taxes is -$5200.00
What is Clearmind Medicine TTM EBIT year-on-year change?
Over the past year, CMND TTM earnings before interest & taxes has changed by +$3.75 M (+43.67%)